Publication: Development of [18F]ICMT-11 for Imaging Caspase-3/7 Activity during Therapy-Induced Apoptosis
dc.contributor.author | García-Argüello, Segundo Francisco | |
dc.contributor.author | Lopez-Lorenzo, Beatriz | |
dc.contributor.author | Cornelissen, Bart | |
dc.contributor.author | Smith, Graham | |
dc.contributor.authoraffiliation | [García-Argüello,SF] Centro de Investigaciones Médico-Sanitarias, Fundación General Universidad de Málaga, Málaga, Spain. [García-Argüello,SF] Grupo de Arteriosclerosis, Prevención Cardiovascular y Metabolismo, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain. [Lopez-Lorenzo,B] Biomedicina, Investigación Traslacional y Nuevas Tecnologías en Salud, Universidad de Málaga, Málaga, Spain. [Lopez-Lorenzo,B] BIONAND-Centro Andaluz de Nanomedicina y Biotecnología (Junta de Andalucía—Universidad de Málaga), Málaga, Spain. [Cornelissen,B; Smith,G] Department of Oncology, CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Old Road Campus Research Building, Oxford, UK. | |
dc.date.accessioned | 2022-09-27T05:51:59Z | |
dc.date.available | 2022-09-27T05:51:59Z | |
dc.date.issued | 2020-08-06 | |
dc.description.abstract | Insufficient apoptosis is a recognised hallmark of cancer. A strategy to quantitatively measure apoptosis in vivo would be of immense value in both drug discovery and routine patient management. The first irreversible step in the apoptosis cascade is activation of the "executioner" caspase-3 enzyme to commence cleavage of key structural proteins. One strategy to measure caspase-3 activity is Positron Emission Tomography using isatin-5-sulfonamide radiotracers. One such radiotracer is [18F]ICMT-11, which has progressed to clinical application. This review summarises the design and development process for [18F]ICMT-11, suggesting potential avenues for further innovation. | es_ES |
dc.description.version | Yes | es_ES |
dc.identifier.citation | García-Argüello SF, Lopez-Lorenzo B, Cornelissen B, Smith G. Development of [18F]ICMT-11 for Imaging Caspase-3/7 Activity during Therapy-Induced Apoptosis. Cancers. 2020 Aug 6;12(8):2191 | es_ES |
dc.identifier.doi | 10.3390/cancers12082191 | es_ES |
dc.identifier.essn | 2072-6694 | |
dc.identifier.pmc | PMC7465189 | |
dc.identifier.pmid | 32781531 | es_ES |
dc.identifier.uri | http://hdl.handle.net/10668/4148 | |
dc.journal.title | Cancers | |
dc.language.iso | en | |
dc.page.number | 16 p. | |
dc.publisher | MDPI | es_ES |
dc.relation.publisherversion | https://www.mdpi.com/2072-6694/12/8/2191/htm | es_ES |
dc.rights | Atribución 4.0 Internacional | * |
dc.rights.accessRights | Acceso abierto | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | Positron emission tomography | es_ES |
dc.subject | Apoptosis | es_ES |
dc.subject | Caspase-3 | es_ES |
dc.subject | [18F]ICMT-11 | es_ES |
dc.subject | Pyrimidoindolone | es_ES |
dc.subject | Michael acceptor | es_ES |
dc.subject | Neoplasms | es_ES |
dc.subject | Isatin | es_ES |
dc.subject | Tomografía de emisión de positrones | es_ES |
dc.subject | Caspasa-3 | es_ES |
dc.subject | Neoplasias | es_ES |
dc.subject | Isatina | es_ES |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Hydrolases::Peptide Hydrolases::Cysteine Proteases::Cysteine Endopeptidases::Caspases::Caspases, Effector::Caspase 3 | es_ES |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 2-Ring::Indoles::Isatin | es_ES |
dc.subject.mesh | Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Diagnostic Techniques, Radioisotope::Radionuclide Imaging::Tomography, Emission-Computed::Positron-Emission Tomography | es_ES |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Oxidoreductases::NADH, NADPH Oxidoreductases::Apoptosis Inducing Factor | es_ES |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Organic Chemicals::Amides::Sulfonamides | es_ES |
dc.subject.mesh | Medical Subject Headings::Diseases::Neoplasms | es_ES |
dc.subject.mesh | Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Drug Discovery | es_ES |
dc.subject.mesh | Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans | es_ES |
dc.title | Development of [18F]ICMT-11 for Imaging Caspase-3/7 Activity during Therapy-Induced Apoptosis | es_ES |
dc.type | review article | |
dc.type.hasVersion | VoR | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- GarciaArgüello_DevelopmentOf.pdf
- Size:
- 5.12 MB
- Format:
- Adobe Portable Document Format
- Description:
- Revisión